个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Zhang, Hui[1] * ; Kong, Haishen[2] ; Yu, Yunsong[3] ; Wu, Anhua[4] ; Duan, Qiong[5] ; Jiang, Xiaofeng[6] ; Zhang, Shufang[7] ; Sun, Ziyong[8] ; Ni, Yuxing[9] ; Wang, Weiping[10] ; Wang, Yong[11] ; Liao, Kang[12] ; Li, Huayin[13] ; Yang, Chunxia[14] ; Huang, Wenxiang[15] ; Gui, Bingdong[16] ; Shan, Bin[17] ; Badal, Robert[18] ; Yang, Qiwen[1] ; Xu, Yingchun[1] ;
单位： [1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Div Microbiol, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China [2]Zhejiang Univ, Dept Microbiol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China [3]Zhejiang Univ, Sch Med, Dept Infect Dis, SirRunRun Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China [4]Cent S Univ, Infect Control Ctr, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China [5]Jilin Prov Peoples Hosp, Microbiol Lab, Changchun 130021, Jilin, Peoples R China [6]Harbin Med Univ, Hosp 4, 37 Yiyuan Rd, Harbin, Heilongjiang, Peoples R China [7]Haikou Peoples Hosp, Div Microbiol, Haikou 570208, Hainan, Peoples R China [8]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Lab Med, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China [9]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Div Microbiol, Shanghai 200025, Peoples R China [10]Nanjing Gen Hosp, 305 Zhongshan Dong Rd, Nanjing, Jiangsu, Peoples R China [11]Shandong Univ, Dept Lab Med, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China [12]Sun Yat Sen Univ, Affiliated Hosp 1, Div Microbiol, Guangzhou 510080, Guangdong, Peoples R China [13]Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China [14]Beijing Chao Yang Hosp, 8 Gongren Tiyuchang Nanlu, Beijing 100020, Peoples R China [15]Chongqing Med Univ, Affiliated Hosp 1, Div Microbiol, Chongqing 400016, Peoples R China [16]Nanchang Univ, Affiliated Hosp 2, Clin Lab, Nanchang 330006, Jiangxi, Peoples R China [17]Kunming Med Univ, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China [18]Int Hlth Management Associates, Div Microbiol, Schaumburg, IL 60173 USA
出处：
DOI： 10.1186/s12879-018-3405-1
ISSN：

关键词： Enterobacteriaceae Carbapenem ertapenem Imipenem Intra-abdominal infection Urinary tract infection

摘要：
Background: To evaluate the susceptibility rates of aerobic and facultative Gram-negative bacterial isolates from Chinese intra-abdominal infections (IAI) and urinary tract infections (UTI) focusing on carbapenems and comparing their effectiveness between 2014 and 2015. Methods: A total of 2318 strains in 2015 (1483 from IAI and 835 from UTI) and 2374 strains in 2014 (1438 from IAI and 936 from UTI) were included in the analysis. Antimicrobial susceptibilities were determined at a central laboratory using CLSI broth microdilution and interpretive standards. Hospital acquired (HA) IAI and UTI were defined as isolates sampled > 48 h and community acquired (CA) as isolates sampled < 48 h after admission. Results: The main species derived from IAI and UTI in 2015 were Escherichia coli (50.86%) and Klebsiella pneumoniae (19.20%). Susceptibilities of Escherichia coli IAI and UTI strains to imipenem (IPM) and ertapenem (ETP) were > 90% in 2014 and 2015, while the susceptibilities to IPM and ETP of Klebsiella pneumoniae IAI strains were > 80% in 2014 but dropped to <= 80% in 2015 for UTI strains. Susceptibilities of IAI Enterobacteriaceae strains to IPM and ETP in 2015 were lowest in the colon and abscesses, and Enterobacteriaceae susceptibilities of UTI and IAI isolates to IPM and ETP were lowest in medical, pediatric and surgery intensive care units (ICUs) in 2015. Conclusions: IPM and ETP were effective in vitro against Enterobacteriaceae isolated from IAIs and UTIs in 2014 and 2015, but susceptibility to carbapenems in UTIs markedly decreased in 2015.

基金：
Outstanding Talents Training Funding Project of Dongcheng District, Beijing; National Key Research and Development Program of China [SQ2018YFC120102]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-014]; CAMS Initiative for Innovative Medicine [2016-I2M-3-014]; Merck Sharp Dohme (MSD; Whitehouse Station, NJ, USA)
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2017]版：
大类 | 3 区 医学
小类 | 3 区 传染病学
最新[2025]版：
大类 | 3 区 医学
小类 | 3 区 传染病学
JCR分区：
出版当年[2016]版：
Q2 INFECTIOUS DISEASES
最新[2024]版：
Q2 INFECTIOUS DISEASES

影响因子： 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者：
第一作者单位： [1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Div Microbiol, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang Hui,Kong Haishen,Yu Yunsong,et al.Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China[J].BMC INFECTIOUS DISEASES.2018,18:doi:10.1186/s12879-018-3405-1.
APA：
Zhang, Hui,Kong, Haishen,Yu, Yunsong,Wu, Anhua,Duan, Qiong...&Xu, Yingchun.(2018).Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China.BMC INFECTIOUS DISEASES,18,
MLA：
Zhang, Hui,et al."Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China".BMC INFECTIOUS DISEASES 18.(2018)

相关文献

[1]A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection [2]In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015-2018 [3]Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial [4]Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection [5]Risk Factors for Urosepsis after Minimally Invasive Percutaneous Nephrolithotomy in Patients with Preoperative Urinary Tract Infection [6]Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients [7]复杂性腹腔感染的营养支持治疗 [8]Incidence and risk factors of urinary tract infection in hospitalized patients with spinal cord injury in a hospital of China [9]Emerione A, a novel fungal metabolite as an inhibitor of New Delhi metallo-β-lactamase 1, restores carbapenem susceptibility in carbapenem-resistant isolates [10]Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii

资源点击量：898 今日访问量：1 总访问量：636 更新日期：2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）